MokCCYapDYHNavarraSVAsian Lupus Nephritis Network ALNN, et al.Overview of lupus nephritis management guidelines and perspective from Asia. Nephrology (Carlton)2014; 19: 11–20.
2.
FanouriakisAKostopoulouMAlunnoA, et al.2019 update of the EULAR recommendations for the management of systemic lupus erythematosus. Ann Rheum Dis. 2019; 78: 736–745.
3.
TanakaHWatanabeSAizawa-YashiroT, et al.Long-term tacrolimus-based immunosuppressive treatment for young patients with lupus nephritis: a prospective study in daily clinical practice. Nephron Clin Pract2012; 121: c165–c173.
4.
KarasawaKUchidaKKodamaM, et al.Long-term effects of tacrolimus for maintenance therapy of lupus nephritis: a 5-year retrospective study at a single center. Rheumatol Int2018; 38: 2271–2277.
5.
YapDYHMaMKMMokMMY, et al.Long-term data on tacrolimus treatment in lupus nephritis. Rheumatology (Oxford)2014; 53: 2232–2237.
6.
TanakaHTsurugaKWatanabeS, et al.Tacrolimus monotherapy in a patient with lupus flare using once-daily administration protocol. NDT Plus2011; 4: 363–365.
7.
AustinHAMuenzLRJoyceKM, et al.Diffuse proliferative lupus nephritis: identification of specific pathologic features affecting renal outcome. Kidney Int1984; 25: 689–695.
